Sage Journals: Discover world-class research

Retricted access

Review article

First published 2015-5

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Tablets for Hepatitis C Virus Genotype 1 Infection

Olga M. Klibanov, Stormi E. Gale, Barbara Santevecchi

Annals of Pharmacotherapy

Free access

Research article

First published 2019-6

Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy

Carmen M Preda, Cristian Baicus, Irina Sandra [...]

United European Gastroenterology Journal

Retricted access

Review article

First published 2015-5

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir

Dennis J. Cada, James Leonard, Terri L. Levien [...]

Hospital Pharmacy

Free access

Research article

First published 2016-11

Effect of Co-Medications on Paritaprevir,Ritonavir,Ombitasvir,Dasabuvir and Ribavirin Pharmacokinetics: Analysis of Data from Seven Phase II/III Trials

Akshanth R Polepally, Prajakta S Badri, Apurvasena Parikh [...]

Antiviral Therapy

Retricted access

Research article

First published 2016-11

Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

Esther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen Guadalupe Rodriguez-Gonzalez [...]

Annals of Pharmacotherapy

Free access

Review article

First published 2015-9

The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment

Brian P. Lam, Thomas Jeffers, Zahra Younoszai [...]

Therapeutic Advances in Gastroenterology

Retricted access

Letter

First published 2018-4

Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Therapy–Related Severe Anemia

Hayretdin Koklu, Tuğrul Pürnak, Nomingerel Tseveldorj [...]

Annals of Pharmacotherapy

Free access

Research article

First published 2017-11

Real-World Efficacy and Safety of Ritonavir-Boosted Paritaprevir,Ombitasvir,Dasabuvir ± Ribavirin for Hepatitis C Genotype 1 – Final Results of the REV1TAL Study

the Australian Liver Association Clinical Research Network (ALA CRN), John Lubel, Simone Strasser [...]

Antiviral Therapy

Free access

Review article

First published 2018-1

Expert Opinion on the Management of Renal Manifestations of Chronic HCV Infection

Fabrizio Fabrizi, Francesco Negro, Mark Bondin [...]

Antiviral Therapy

Retricted access

Review article

First published 2015-6

Drug Interactions With Direct-Acting Antivirals for Hepatitis C

Sarah Burgess, Nilufar Partovi, Eric M. Yoshida [...]

Annals of Pharmacotherapy

Search results